Healthcare provider profile · identity verified

Ariel Rodriguez, M.D.

Family Practice · BROOKLYN, NY · NPI 1851344790

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	661	180
Amlodipine Besylate	Amlodipine Besylate	628	171
Famotidine	Famotidine	343	80
Levothyroxine Sodium	Levothyroxine Sodium	311	78
Metformin Hcl	Metformin Hcl	294	74
Albuterol Sulfate Hfa	Albuterol Sulfate	267	59
Vitamin D2	Ergocalciferol (Vitamin D2)	256	47
Hydrochlorothiazide	Hydrochlorothiazide	247	64
Pioglitazone Hcl	Pioglitazone Hcl	232	56
Metoprolol Succinate	Metoprolol Succinate	223	62
Losartan Potassium	Losartan Potassium	211	51
Rosuvastatin Calcium	Rosuvastatin Calcium	206	67
Omeprazole	Omeprazole	198	41
Pravastatin Sodium	Pravastatin Sodium	198	54
Gabapentin	Gabapentin	196	54
Tamsulosin Hcl	Tamsulosin Hcl	190	50
Jardiance	Empagliflozin	186	39
Alendronate Sodium	Alendronate Sodium	182	39
Enalapril Maleate	Enalapril Maleate	174	43
Furosemide	Furosemide	143	31
Trazodone Hcl	Trazodone Hcl	142	31
Lisinopril	Lisinopril	132	35
Montelukast Sodium	Montelukast Sodium	125	31
Fluticasone Propionate	Fluticasone Propionate	120	39
Metformin Hcl Er	Metformin Hcl	120	27
Pantoprazole Sodium	Pantoprazole Sodium	117	25
Simvastatin	Simvastatin	113	28
Azelastine Hcl	Azelastine Hcl	112	24
Januvia	Sitagliptin Phosphate	96	20
Metoprolol Tartrate	Metoprolol Tartrate	96	27
Trulicity	Dulaglutide	88	13
Glimepiride	Glimepiride	84	19
Ramipril	Ramipril	84	22
Ezetimibe	Ezetimibe	79	23
Finasteride	Finasteride	79	20
Meclizine Hcl	Meclizine Hcl	74	21
Mirtazapine	Mirtazapine	74	17
Escitalopram Oxalate	Escitalopram Oxalate	70	16
Ozempic	Semaglutide	67	12
Clopidogrel	Clopidogrel Bisulfate	66	17
Meloxicam	Meloxicam	63	17
Valsartan	Valsartan	60	17
Eliquis	Apixaban	59	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	55	14
Buspirone Hcl	Buspirone Hcl	55	15
Vascepa	Icosapent Ethyl	55	11
Donepezil Hcl	Donepezil Hcl	47	12
Ibandronate Sodium	Ibandronate Sodium	47	11
Farxiga	Dapagliflozin Propanediol	45	suppressed
Hydrocortisone	Hydrocortisone	45	suppressed
Mupirocin	Mupirocin	43	21
Ketoconazole	Ketoconazole	42	11
Sertraline Hcl	Sertraline Hcl	42	suppressed
Carvedilol	Carvedilol	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Procto-Med Hc	Hydrocortisone	40	11
Potassium Chloride	Potassium Chloride	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Memantine Hcl	Memantine Hcl	37	suppressed
Ammonium Lactate	Ammonium Lactate	36	17
Benazepril Hcl	Benazepril Hcl	36	suppressed
Glipizide	Glipizide	36	suppressed
Single Use Swab	Alcohol Antiseptic Pads	36	suppressed
Chlorthalidone	Chlorthalidone	35	11
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Atenolol	Atenolol	34	13
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Estradiol	Estradiol	33	13
Janumet	Sitagliptin Phos/Metformin Hcl	33	suppressed
Memantine Hcl Er	Memantine Hcl	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	17
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Rybelsus	Semaglutide	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	13
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Cilostazol	Cilostazol	22	suppressed
Ibuprofen	Ibuprofen	21	18
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Ranolazine Er	Ranolazine	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Torsemide	Torsemide	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	16
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Hyoscyamine Sulfate	Hyoscyamine Sulfate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Indapamide	Indapamide	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Restasis	Cyclosporine	15	suppressed
Linzess	Linaclotide	14	suppressed
Nystatin	Nystatin	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Azithromycin	Azithromycin	13	13
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error